Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population
Background. The Surveillance, Epidemiology and End Results (SEER)-Medicare–linked
database combines clinical information from population-based cancer registries with claims …
database combines clinical information from population-based cancer registries with claims …
Review of the evidence: prevalence of medical conditions in the United States population with serious mental illness
EM Janssen, EE McGinty, ST Azrin… - General hospital …, 2015 - Elsevier
Objective Persons with serious mental illness (SMI) have high rates of premature mortality
from preventable medical conditions, but this group is underrepresented in epidemiologic …
from preventable medical conditions, but this group is underrepresented in epidemiologic …
Cerebral venous thrombosis and portal vein thrombosis: a retrospective cohort study of 537,913 COVID-19 cases
Background There are concerns about a link between the ChAdOx1 nCoV-19 and Ad26.
COV2. S vaccines against COVID-19 and cerebral venous thrombosis (CVT) and other …
COV2. S vaccines against COVID-19 and cerebral venous thrombosis (CVT) and other …
[图书][B] Applications of prediction models
EW Steyerberg, EW Steyerberg - 2009 - Springer
Applications of prediction models | SpringerLink Skip to main content Advertisement
SpringerLink Account Menu Find a journal Publish with us Track your research Search Cart …
SpringerLink Account Menu Find a journal Publish with us Track your research Search Cart …
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer
DL Hershman, T Shao, LH Kushi, D Buono… - Breast cancer research …, 2011 - Springer
Despite the benefit of adjuvant hormonal therapy (HT) on mortality among women with
breast cancer (BC), many women are non-adherent with its use. We investigated the effects …
breast cancer (BC), many women are non-adherent with its use. We investigated the effects …
Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study
JL Patnaik, T Byers, C DiGuiseppi, D Dabelea… - Breast Cancer …, 2011 - Springer
Introduction Many women who survive breast cancer die of causes unrelated to their cancer
diagnosis. This study was undertaken to assess factors that are related to breast cancer …
diagnosis. This study was undertaken to assess factors that are related to breast cancer …
Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer
J Chen, JB Long, A Hurria, C Owusu… - Journal of the American …, 2012 - jacc.org
Objectives: The purpose of this study was to estimate heart failure (HF) and cardiomyopathy
(CM) rates after adjuvant trastuzumab therapy and chemotherapy in a population of older …
(CM) rates after adjuvant trastuzumab therapy and chemotherapy in a population of older …
Risk of myocardial infarction in older men receiving testosterone therapy
J Baillargeon, RJ Urban, YF Kuo… - Annals of …, 2014 - journals.sagepub.com
Background: Testosterone therapy for older men has increased substantially over the past
decade. Research on the effects of testosterone therapy on cardiovascular outcomes has …
decade. Research on the effects of testosterone therapy on cardiovascular outcomes has …
Complications following colonoscopy with anesthesia assistance: a population-based analysis
Importance Deep sedation for endoscopic procedures has become an increasingly used
option but, because of impairment in patient response, this technique also has the potential …
option but, because of impairment in patient response, this technique also has the potential …
Risk prediction model for heart failure and cardiomyopathy after adjuvant trastuzumab therapy for breast cancer
Background Adjuvant trastuzumab improves survival for women with human epidermal
growth factor receptor 2‐positive breast cancer, but increases risk for heart failure (HF) and …
growth factor receptor 2‐positive breast cancer, but increases risk for heart failure (HF) and …